GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Beyond Air Inc.
Beyond Air is a medical device company developing a nitric oxide delivery system. Its stock price is a bet on FDA approval and commercial success for this system. The chart reflects the long and arduous journey from development to market.
Share prices of companies in the market segment - Therapeutic medical equipment
Beyond Air is a medical device company developing the LungFit system for generating nitric oxide, which is used to treat lung conditions in newborns and adults. We've categorized it as "Therapeutic Medical Equipment." The graph below shows the dynamics in the respiratory therapy sector.
Broad Market Index - GURU.Markets
Beyond Air is a medical device company developing a system for generating and delivering nitric oxide to treat respiratory conditions. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Beyond Air compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
XAIR - Daily change in the company's share price Beyond Air Inc.
Beyond Air, Inc.'s daily stock price fluctuations reflect the volatility of the medical device sector. This metric measures the company's sensitivity to news of the approval and commercialization of its nitric oxide delivery system.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Beyond Air develops innovative medical equipment, and its stock volatility is highly dependent on news and regulatory approvals. The chart below shows the average daily price swings for the sector. This benchmark provides a clearer understanding of how sensitive XAIR shares are to events compared to its peers.
Daily change in the price of a broad market stock, index - GURU.Markets
Beyond Air is developing an innovative nitric oxide-based therapy for the treatment of lung diseases. This medtech company's shares are reacting to clinical successes and regulatory decisions, contributing to the overall volatility in the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Beyond Air Inc.
Beyond Air, Inc.'s year-over-year performance is a story of the commercialization of its nitric oxide (NO) delivery system. Its 12-month market cap growth reflects FDA approval and the launch of its LungFit PRO system for the treatment of pulmonary hypertension in newborns, a fundamental milestone for the company.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Beyond Air, Inc. is a commercial medical device company that has developed a nitric oxide delivery system. Its success depends on the widespread adoption of this innovative product in hospitals. The chart below shows how the market views its technology and its path to profitability in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Beyond Air, with its nitric oxide delivery system, is a story of medical technology innovation. Its performance relative to the market reflects the long journey from development to commercialization. Each step—FDA approval, the launch of sales—is a powerful driver, capable of sending the stock ahead of the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Beyond Air Inc.
Beyond Air is a commercial medical device company developing nitric oxide delivery systems. Its monthly growth is driven by sales growth of its LungFit system. Quarterly revenue reports and progress in securing approvals for new indications are key.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Beyond Air is a medical device company developing the LungFit system for delivering nitric oxide to treat pulmonary conditions, from neonatal hypertension to viral pneumonia. The graph below illustrates the dynamics of the medical device sector, where innovative therapies have the potential to transform treatment standards.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. It's a medical startup whose valuation is based on the potential of its technology. Its shares are driven by news of clinical trials and FDA approvals, completely ignoring overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Beyond Air Inc.
Beyond Air is developing nitric oxide-based therapies. Its weekly stock price is volatile and depends on regulatory approvals for new indications and the pace of commercialization.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Beyond Air, Inc. develops therapeutic medical devices. This chart compares the company's weekly stock performance with its sector. Are price fluctuations driven by unique product news and approvals, or are they simply a reflection of general sentiment in the medtech industry?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Beyond Air, Inc., as a medical technology company, should be less dependent on economic cycles. The chart will show how insulated the company's shares are from general market fluctuations, moving with product news and regulatory decisions while ignoring macroeconomic noise.
Market capitalization of the company, segment and market as a whole
XAIR - Market capitalization of the company Beyond Air Inc.
Beyond Air's chart tells the story of nitric oxide's medical applications. Its market cap reflects investors' belief that the company's portable system could become a new standard for treating lung diseases in newborns and potentially find application in other areas of medicine.
XAIR - Share of the company's market capitalization Beyond Air Inc. within the market segment - Therapeutic medical equipment
Beyond Air is developing an innovative system for generating nitric oxide (NO) from ambient air for therapeutic use. Its market capitalization in the medical equipment segment reflects the revolutionary potential of this technology. The company's size is a bet that its portable device will replace bulky and expensive NO cylinders in hospitals.
Market capitalization of the market segment - Therapeutic medical equipment
Beyond Air is developing nitric oxide-based therapy. How big is this niche? The chart below shows the overall market capitalization of the therapeutic device sector. Its growth reflects the ongoing search for new non-antibiotic treatments for lung diseases and infections.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Beyond Air chart shows how the market values a nitric oxide-based medical technology. The company's market cap is a bet on its ability to gain approval and implement its system for treating lung diseases. This diagram illustrates the long journey from development to clinical practice.
Book value capitalization of the company, segment and market as a whole
XAIR - Book value capitalization of the company Beyond Air Inc.
Beyond Air's assets include its manufacturing facilities for the LungFit nitric oxide system, as well as its R&D infrastructure. Its book value reflects the value of these high-tech medical assets. The chart below shows how the company has invested its capital.
XAIR - Share of the company's book capitalization Beyond Air Inc. within the market segment - Therapeutic medical equipment
Beyond Air, Inc. develops nitric oxide therapy. Its tangible assets include R&D laboratories and production lines for its innovative generators and gas delivery systems. The chart shows the company's control over this unique medical manufacturing infrastructure.
Market segment balance sheet capitalization - Therapeutic medical equipment
Beyond Air is developing a nitric oxide therapy system. The medical equipment sector, as the chart shows, is capital-intensive. Beyond Air is an innovator. Its capital is invested in R&D and production of a unique device that could change the approach to treatment.
Book value of all companies included in the broad market index - GURU.Markets
Beyond Air's assets are not drugs, but rather production facilities for the compact LungFit system, which generates nitric oxide from ambient air to treat lung diseases. Its book value reflects its industrial and technological potential in this field.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Beyond Air Inc.
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. Its value lies in this medical platform. The chart shows how the market views its progress toward regulatory approval and its commercial prospects.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Beyond Air is developing a system for generating nitric oxide for medical use. Its value lies in its patented technology. The chart shows how the market perceives the potential of its medical device to change treatment standards in several areas.
Market to book capitalization ratio for the market as a whole
Beyond Air, Inc. is developing nitric oxide-based therapy. Its valuation depends entirely on successful regulatory approvals and commercialization of the technology. This chart demonstrates how intangible assets such as patents and clinical data are the primary source of value for healthcare companies.
Debts of the company, segment and market as a whole
XAIR - Company debts Beyond Air Inc.
Beyond Air is developing a nitric oxide-based medical system for the treatment of lung infections. Bringing new medical devices to market is a long process, requiring funding for clinical trials, obtaining approvals, and establishing a manufacturing base. This chart shows how the company is raising capital to complete these steps.
Market segment debts - Therapeutic medical equipment
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. Commercializing a medical device is a lengthy and expensive process. This chart shows how the company is funding its clinical trials, regulatory engagement, and preparation for market entry.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Beyond Air Inc.
Beyond Air is developing a nitric oxide-based medical device. This chart shows its financial structure. For a company whose success depends on regulatory approval and medical acceptance of its technology, debt is a major risk. It could deplete its financial resources even before the product begins generating stable revenue.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Beyond Air is developing a nitric oxide delivery system for the treatment of lung infections and other diseases. This is an innovative approach to respiratory medicine. The chart shows the overall debt burden in the sector, providing context for assessing how the company is funding its expensive clinical trials and regulatory approval process.
Debt to book value of all companies in the market
Beyond Air, Inc. is developing a nitric oxide delivery system for the treatment of lung diseases. While in the commercialization phase, the company incurs significant marketing and manufacturing costs. This chart helps understand the financing options—debt or equity—available to Beyond Air to bring its innovative technology to market.
P/E of the company, segment and market as a whole
P/E - Beyond Air Inc.
This metric for Beyond Air, a medical company developing nitric oxide-based therapy, reflects expectations for its product. The P/E (if established) will be based on investors' belief that its portable system can become a new standard of care in its niche and capture a significant market.
P/E of the market segment - Therapeutic medical equipment
Beyond Air is a commercial medical technology company that developed the LungFit system for on-demand nitric oxide generation to treat lung diseases. This chart shows the average valuation for the sector, helping to understand how the market views this innovative therapeutic platform.
P/E of the market as a whole
Beyond Air is developing a medical device for delivering nitric oxide to treat lung diseases. Its valuation is a pure bet on regulatory approval and commercial success of this technology. It is not tied to the general economic cycles reflected here, but depends entirely on clinical and regulatory developments.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Beyond Air Inc.
Beyond Air is developing a medical device for generating nitric oxide (NO) from ambient air to treat lung diseases. This chart reflects investor expectations for the commercialization of this technology. The valuation is based on the potential to offer a cheaper and more accessible alternative to existing balloon-based NO therapy.
%20P%2FE%20Beyond%20Air%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Beyond-Air-Inc.&v=1772649084255 "Chart of the company's future (projected) P/E Beyond Air Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Beyond Air develops a medical device for delivering nitric oxide to treat lung diseases. Its valuation relative to other companies in the medical device sector reflects investor expectations for its innovative LungFit system. This demonstrates whether investors believe it can gain approval and change the standard of care.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772649084264 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. The company aims to offer a more convenient and affordable alternative to existing treatments. This chart reflects the overall risk appetite of investors. For medical companies challenging established treatment standards, investor confidence in their technology and their ability to win market share is crucial.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772649084267 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Beyond Air Inc.
Beyond Air is developing an innovative system for generating nitric oxide, which is used to treat lung diseases. Financial results presented here are contingent on regulatory approvals and the implementation of this therapeutic platform in hospitals worldwide.
Profit of companies in the market segment - Therapeutic medical equipment
Beyond Air is developing a nitric oxide delivery system for the treatment of lung infections and other conditions. This chart shows the overall profitability of the therapeutic medical device sector. It helps understand the market's readiness for the introduction of new gas therapy methods and the potential for commercial success.
Overall market profit
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. This medical device has potential applications in a variety of fields. The company's success depends on regulatory approvals and the acceptance of the technology by physicians. The overall economic situation, as reflected in the chart, has little impact on this process.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Beyond Air Inc.
Beyond Air is developing a medical device for delivering nitric oxide, which is used to treat lung diseases. The company's future revenue is dependent on FDA approval and the commercial launch of the product. This graph reflects analysts' expectations regarding the acceptance of this new therapeutic system by the medical community.
%20profit%20of%20the%20company%20Beyond%20Air%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Beyond-Air-Inc.&v=1772649084284 "Graph of future (projected) profit of the company Beyond Air Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Beyond Air is developing a nitric oxide (NO) delivery system for the treatment of lung diseases. Their portable device could make this therapy more accessible than existing, bulky systems. This chart shows forecasts for the therapeutic medical device sector, illustrating the potential for innovations that could change treatment standards and expand markets.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772649084292 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
For Beyond Air, a medical equipment company, this schedule is important for hospital and clinic budgets. Economic growth allows medical institutions to invest in innovative therapeutic systems. During periods of budget constraints, the adoption of new technologies may be delayed.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772649084301 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Beyond Air Inc.
Beyond Air is developing a nitric oxide delivery system to treat lung diseases. This chart shows how investors view its early revenue and the enormous potential of its therapeutic platform for use in hospitals worldwide.
P/S market segment - Therapeutic medical equipment
Beyond Air is developing an innovative system for generating nitric oxide from ambient air for therapeutic use in the treatment of lung diseases. This chart shows the average valuation in the therapeutic medical equipment sector. It reflects investor expectations for a technology that could make nitric oxide therapy more accessible and convenient.
P/S of the market as a whole
Beyond Air, Inc. is a medical device company developing a nitric oxide generation system for the treatment of lung diseases. Nitric oxide is an important gas in medicine, and the company offers an innovative method for delivering it. Future revenue is dependent on approval and implementation. This chart helps estimate expectations for innovation in medical technology.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Beyond Air Inc.
Beyond Air is developing a nitric oxide-based system for the treatment of lung diseases. Future revenue depends on the approval and implementation of its technology in hospitals. This chart shows how the market perceives the potential of this innovative therapeutic platform to become a new standard of care and generate sales.
%20P%2FS%20Beyond%20Air%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Beyond-Air-Inc.&v=1772649084330 "The graph of the company's future (projected) P/S Beyond Air Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Beyond Air is developing a nitric oxide (NO) delivery system for the treatment of lung diseases. Unlike existing systems, its device generates NO from ambient air, making it portable and affordable. This chart shows how the market is assessing the potential of this innovative therapeutic platform.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772649084333 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
This reflects investors' faith in innovative medical gases. For Beyond Air, a company developing a nitric oxide delivery system for treating lung diseases, this is an indicator of the acceptance of new therapies. Market optimism is helping fund the launch of systems that could become the new standard of care.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772649084342 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Beyond Air Inc.
Beyond Air is developing an innovative system for generating and delivering nitric oxide (NO) for therapeutic purposes. This graph will reflect revenue from sales of the LungFit device for the treatment of pulmonary hypertension in neonates. Increased sales will mean the displacement of traditional, bulky balloon-based systems and the adoption of this new technology by hospitals.
Sales of companies in the market segment - Therapeutic medical equipment
Beyond Air, Inc. is developing a system for generating nitric oxide from ambient air for therapeutic use. This graph illustrates the growth of the therapeutic medical equipment market. Beyond Air's innovative technology could replace bulky and expensive cylinders, making nitric oxide therapy accessible for a wide range of conditions.
Overall market sales
Beyond Air, Inc. is developing a medical device for delivering nitric oxide to treat lung diseases. Demand for its technology will depend on its implementation in hospitals. The overall economic environment, shown in this graph, influences healthcare facilities' budgets and their willingness to invest in innovative therapeutic equipment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Beyond Air Inc.
Beyond Air is developing an innovative system for generating nitric oxide (NO) from ambient air, which can be used to treat lung diseases. The company's future depends on the approval and implementation of this medical technology. This timeline reflects analysts' expectations for the commercial potential of this new approach to respiratory therapy.
%20sales%20of%20the%20company%20Beyond%20Air%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Beyond-Air-Inc.&v=1772649084366 "Schedule of future (projected) sales of the company Beyond Air Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. This chart shows expectations for the therapeutic medical device sector. It reflects the need for innovative treatments for respiratory infections, a key market opportunity for Beyond Air.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772649084376 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Beyond Air, Inc. is a biopharmaceutical company developing a nitric oxide delivery system for the treatment of lung diseases. Commercial success depends on regulatory approval and hospital acceptance. This timeline, reflecting the overall economic situation, impacts healthcare system budgets and their ability to invest in new medical technologies.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772649084379 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Beyond Air Inc.
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. This chart shows the financial outlook at the commercialization stage. Profitability will depend on the successful launch of the system, its acceptance by hospitals, and reimbursement from insurance companies, which requires significant marketing efforts.
Market segment marginality - Therapeutic medical equipment
Beyond Air is developing an innovative nitric oxide delivery system for the treatment of lung diseases. For a medical device company, profitability depends on the effectiveness of the technology and its acceptance by the medical community. This chart shows the average profitability in the sector, helping to assess the commercial potential of their development.
Market marginality as a whole
Beyond Air is developing a nitric oxide delivery system for the treatment of lung diseases. This overall market profitability figure is not key to the company's success. The company's success depends on regulatory approvals and hospital acceptance of its technology. Its market is driven by the medical need for effective and safe treatment.
Employees in the company, segment and market as a whole
Number of employees in the company Beyond Air Inc.
Beyond Air is a company developing a nitric oxide generating system for the treatment of lung diseases. This graph shows the team bringing this innovative medical device to market. The growth in staff reflects the transition from clinical trials to full-scale commercialization.
Share of the company's employees Beyond Air Inc. within the market segment - Therapeutic medical equipment
Beyond Air is developing an innovative nitric oxide delivery system for the treatment of lung infections and other diseases. This chart shows the proportion of biomedical engineers, chemists, and clinicians the company is attracting in this narrow therapeutic niche. It reflects its concentration of talent to bring a fundamentally new medical technology to market.
Number of employees in the market segment - Therapeutic medical equipment
Beyond Air is developing a nitric oxide (NO) delivery system for the treatment of lung infections and other conditions. Medical gases are an important part of therapy. This graph illustrates how new treatments emerge at the intersection of chemistry, engineering, and medicine, requiring specialized equipment and the involvement of clinical specialists to use it.
Number of employees in the market as a whole
Beyond Air, Inc. develops innovative medical gas therapies. It's an example of how deep scientific knowledge can be transformed into a commercial product. This graph illustrates the scale of the labor market, which is constantly fueled by such science-intensive startups, turning laboratory research results into real jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Beyond Air Inc. (XAIR)
Beyond Air develops medical devices for delivering nitric oxide (NO) to treat lung diseases. This chart represents the company's net intellectual capital. Its primary asset is the patented LungFit system, not its staff. The chart shows how highly the market values this innovative therapeutic platform and its market potential per employee.
%20of%20the%20company%20Beyond%20Air%20Inc.%20(XAIR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Beyond-Air-Inc.-XAIR&v=1772649084434 "Chart of market capitalization per employee (in thousands of dollars) of the company Beyond Air Inc. (XAIR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Beyond Air, Inc. develops innovative nitric oxide delivery systems for medical applications. In the medical device sector, market capitalization reflects the potential of the technology. This chart shows how highly the market values a team capable of navigating all regulatory processes and bringing a product to market. This is an indicator of confidence in their technological advantage.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772649084456 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Beyond Air, Inc. is a medical device company developing a nitric oxide delivery system for the treatment of lung diseases. This chart shows the average market value of each employee's contribution. It illustrates how the market values innovative medical devices.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772649084472 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Beyond Air Inc. (XAIR)
Beyond Air is a medical company commercializing a nitric oxide delivery system. They are at the intersection of R&D and sales. This chart shows how successfully the company is transitioning from burning money on R&D (loss per employee) to generating profits from sales of its approved device.
%20Chart%20Beyond%20Air%20Inc.%20(XAIR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Beyond-Air-Inc.-XAIR&v=1772649084483 "Company Profit Per Employee (in thousands of dollars) Chart Beyond Air Inc. (XAIR)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Beyond Air, Inc. is developing a nitric oxide delivery system for the treatment of lung diseases. It is a medical technology company whose value lies in its innovative product. During the commercialization phase, this graph shows how successfully the sales and marketing team is bringing the product to market, reflecting the financial return on each employee and the market acceptance of the technology.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772649084484 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Beyond Air (XAIR) is a MedTech company developing the LungFit system for generating nitric oxide (NO) from air and delivering it to patients with respiratory diseases (such as PPHN in neonates). This R&D and commercialization of medical equipment is underway. This chart shows the average market dollar return per employee. It helps assess how effective XAIR's MedTech (IP) model is in generating profits.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772649084491 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Beyond Air Inc. (XAIR)
Beyond Air is developing a medical device for delivering nitric oxide to treat lung diseases. This graph shows the path from approval to commercialization. Growth in this indicator will indicate successful implementation of the system in hospitals and the company's ability to generate stable revenue for its team.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Beyond-Air-Inc.-XAIR&v=1772649084508 "Sales chart per company employee Beyond Air Inc. (XAIR)")
Sales per employee in the market segment - Therapeutic medical equipment
Beyond Air is developing a nitric oxide (NO) delivery system for the treatment of lung diseases. It's an innovative medical technology company. This graph shows the average revenue per employee in the segment. It helps evaluate how effectively Beyond Air's team (R&D, sales) is commercializing its system compared to other medical device manufacturers.
Sales per employee for the market as a whole
Beyond Air is developing a medical device for generating nitric oxide (NO) on-demand to treat lung diseases. The company is in the early stages of commercialization. This chart is key. It demonstrates how effectively their new sales team is beginning to promote their innovative therapeutic system to hospitals.
Short shares by company, segment and market as a whole
Shares shorted by company Beyond Air Inc. (XAIR)
Beyond Air is developing a medical device for delivering nitric oxide (NO) to treat lung diseases. The company is burning through capital trying to secure FDA approval. This chart shows the odds that they won't make it. The bears believe the approval process will drag on, competitors will beat them to it, and the company will run out of cash.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Beyond-Air-Inc.-XAIR&v=1772649084559 "Short Shares Chart for the Company Beyond Air Inc. (XAIR)")
Shares shorted by market segment - Therapeutic medical equipment
Beyond Air, Inc. (XAIR) is developing an inhaled nitric oxide (NO) system for the treatment of lung infections and pulmonary hypertension. Their goal is to offer an alternative to bulky cylinders. This chart illustrates the overall bearish sentiment in the therapeutic medical equipment sector. A rising figure may indicate that investors expect a slowdown in the adoption of new medical devices in hospitals.
Shares shorted by the overall market
Beyond Air is developing a nitric oxide (NO) delivery system for the treatment of lung diseases. It's a medical technology company at the intersection of pharmaceuticals. This chart illustrates the overall market pessimism. As fear mounts, investors become skeptical of companies whose products haven't yet become the "gold standard." They fear slow market adoption and XAIR's problems with R&D funding.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Beyond Air Inc. (XAIR)
Beyond Air is developing an innovative nitric oxide delivery system (LungFit) for the treatment of lung infections in hospitalized patients. This medical technology is awaiting widespread adoption. This chart measures the market's reaction to news of FDA approval or hospital partnerships, reflecting "overheated" (above 70) or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Beyond-Air-Inc.-XAIR&v=1772649084593 "RSI 14 indicator chart for the company's stock Beyond Air Inc. (XAIR)")
RSI 14 Market Segment - Therapeutic medical equipment
Beyond Air is a medical device company that developed the LungFit system, which generates nitric oxide (NO) from ambient air to treat respiratory conditions, particularly in newborns. This metric reflects the overall momentum in the therapeutic medical device sector. It helps determine whether the entire segment is oversold due to regulatory delays or overheated by expectations.
RSI 14 for the overall market
For Beyond Air, a biotech company in R&D, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast XAIR (Beyond Air Inc.)
Beyond Air is developing a system (LungFit) for delivering nitric oxide (NO) to the lungs. This therapy is intended to treat lung infections and hypertension in neonates. This chart shows the analysts' average 12-month forecast, reflecting their collective bet on FDA approval and commercialization of this system.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-XAIR-Beyond-Air-Inc.&v=1772649084622 "A chart showing analyst consensus forecasts for the expected stock price. XAIR (Beyond Air Inc.)")
The difference between the consensus estimate and the actual stock price XAIR (Beyond Air Inc.)
Beyond Air is a medical technology company developing the LungFit portable system for on-demand nitric oxide (NO) generation. This gas is critical for treating lung diseases. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in the technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-XAIR-Beyond-Air-Inc.&v=1772649084657 "A chart showing the difference between the consensus forecast and the actual stock price. XAIR (Beyond Air Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Beyond Air is a MedTech company that has developed a nitric oxide "generator" (LungFit). It allows for bedside treatment of lung diseases, replacing heavy cylinders. This chart displays analysts' overall expectations for the entire medical device sector, demonstrating whether experts believe in this R&D bet.
Analysts' consensus forecast for the overall market share price
Beyond Air is a medical technology company that developed a system (LungFit) for generating and delivering nitric oxide, used to treat lung infections in infants. This chart shows overall market sentiment. For XAIR, a company with innovative medical technology, the overall optimism is important because it reflects hospitals' willingness to invest in new equipment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Beyond Air Inc.
Beyond Air is a NO inhaler. Their signature product is a portable nitric oxide (NO) generator (LungFit), which they claim can treat severe lung infections (including COVID-19) in the hospital and at home. This chart summarizes their battle with the FDA. It reflects their (very long and so far unsuccessful) path to FDA approval and their desperate fight to keep their money running.
AKIMA Market Segment Index - Therapeutic medical equipment
Beyond Air (XAIR) is a medical technology company developing the LungFit system, a portable device that generates nitric oxide (NO) from air to treat lung infections and hypertension. The chart shows the segment's average index, helping investors assess how this innovative gas therapy stacks up against the market average.
The AKIM Index for the overall market
Beyond Air is a medtech company that developed the LungFit system for generating and delivering nitric oxide to treat lung diseases. This chart, which reflects the market average, is just a backdrop. It helps assess how this device's commercialization story compares to overall macroeconomic trends in medicine.
